Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models
Huichun Tong(Jinan University), Shaogang Qu(Ganzhou People's Hospital)
Cited by 108
Related Papers
Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
|Frontiers in Neuroscience|2020|219
Huntington’s Disease: Complex Pathogenesis and Therapeutic Strategies
|International Journal of Molecular Sciences|2024|92
Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson’s disease
|Cell Death and Disease|2017|63